Intelligencia AI is a health technology company specializing in applying artificial intelligence (AI) to the pharmaceutical industry, aiming to enhance clinical development and decision-making processes. Founded in 2017, the company is headquartered in New York, with additional offices in San Francisco and Athens. Intelligencia AI is recognized as one of The AI Furnace‘s AI Hot 100 startups.
What does Intelligencia AI do?
Intelligencia AI offers AI-powered solutions designed to de-risk drug development by providing accurate assessments of a drug’s probability of success (PoS) and phase transition probabilities. Their flagship product, the Intelligencia Portfolio Optimizer™, is a patented SaaS platform that delivers on-demand access to AI-driven insights based on proprietary data. This platform enables pharmaceutical companies to make informed decisions regarding asset, portfolio, and licensing strategies.
Key Capabilities
- AI-Powered Insights: Provides objective assessments of PoS and phase transitions, enhancing decision-making in drug development.
- Dynamic Benchmarks: Offers comprehensive benchmarks focused on specific indications and phases, aiding in strategic planning.
- Explainable AI: Ensures transparency in AI processes, allowing users to understand the factors driving assessments.
- Comprehensive Data Access: Delivers meticulously curated and harmonized data, facilitating consistent risk evaluation across portfolios.
- Real-Time Tracking: Monitors clinical programs in real-time, organized by proprietary ontologies, to support timely decision-making.
- Validated Predictive Models: Employs AI algorithms with high prospective accuracy (>80%) in predicting FDA approvals for Phase 2 oncology programs.
- Expert Data Curation: Utilizes biomedical professionals for data curation and quality control, ensuring data relevance and accuracy.
Why it stands out
Intelligencia AI distinguishes itself through its patented technology and commitment to transparency in AI-driven assessments. The company’s focus on providing explainable AI solutions addresses common concerns about AI “black boxes,” enabling stakeholders to understand the rationale behind predictions. Additionally, the platform’s high prospective accuracy in predicting FDA approvals for Phase 2 oncology programs underscores its reliability and effectiveness.
Quick Facts
- Founded: 2017
- Headquarters: New York, NY
- Website: intelligencia.ai
- LinkedIn: Intelligencia AI
Keep up to date with our stories on LinkedIn, Twitter , Facebook and Instagram.
